The contribution of oncostatin M (OSM), a member of the interleukin (IL)-6 family already found to be elevated in SSc circulation, and its receptor OSMRβ to SSc-related EndoMT has been recently investigated by Marden et al. [36]. Here, OSM is linked to systemic sclerosis.